Garrido F - Search Results

1

MHC class I antigens, immune surveillance, and tumor immune escape.

Garcia-Lora A, Algarra I, Garrido F. Garcia-Lora A, et al. Among authors: garrido f. J Cell Physiol. 2003 Jun;195(3):346-55. doi: 10.1002/jcp.10290. J Cell Physiol. 2003. PMID: 12704644 Review.

2

Distribution of the CD45R antigen in the maturation of lymphoid and myeloid series: the CD45R negative phenotype is a constant finding in T CD4 positive lymphoproliferative disorders.

Huelin C, Gonzalez M, Pedrinaci S, de la Higuera B, Piris MA, San Miguel J, Ruiz-Cabello F, Garrido F. Huelin C, et al. Among authors: garrido f. Br J Haematol. 1988 Jun;69(2):173-9. doi: 10.1111/j.1365-2141.1988.tb07619.x. Br J Haematol. 1988. PMID: 2968811

3

Different CD45 and CD45R epitopes involved in T cell proliferation and NK cytotoxicity.

Ruiz-Cabello F, Huelin C, Pedrinaci S, Lopez Nevot MA, Garrido F. Ruiz-Cabello F, et al. Among authors: garrido f. Hybridoma. 1989 Feb;8(1):1-11. doi: 10.1089/hyb.1989.8.1. Hybridoma. 1989. PMID: 2466763

4

ACTH and beta-endorphin in transcendental meditation.

Infante JR, Peran F, Martinez M, Roldan A, Poyatos R, Ruiz C, Samaniego F, Garrido F. Infante JR, et al. Among authors: garrido f. Physiol Behav. 1998 Jun 1;64(3):311-5. doi: 10.1016/s0031-9384(98)00071-7. Physiol Behav. 1998. PMID: 9748098 Clinical Trial.

5

Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells.

Bartholomew JS, Glenville S, Sarkar S, Burt DJ, Stanley MA, Ruiz-Cabello F, Chengang J, Garrido F, Stern PL. Bartholomew JS, et al. Among authors: garrido f. Cancer Res. 1997 Mar 1;57(5):937-42. Cancer Res. 1997. PMID: 9041198

6

HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.

Garrido MA, Rodriguez T, Zinchenko S, Maleno I, Ruiz-Cabello F, Concha Á, Olea N, Garrido F, Aptsiauri N. Garrido MA, et al. Among authors: garrido f. Immunogenetics. 2018 Nov;70(10):647-659. doi: 10.1007/s00251-018-1074-2. Epub 2018 Aug 25. Immunogenetics. 2018. PMID: 30145665

7

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.

Aptsiauri N, Ruiz-Cabello F, Garrido F. Aptsiauri N, et al. Among authors: garrido f. Curr Opin Immunol. 2018 Apr;51:123-132. doi: 10.1016/j.coi.2018.03.006. Epub 2018 Mar 19. Curr Opin Immunol. 2018. PMID: 29567511 Review.

8

The urgent need to recover MHC class I in cancers for effective immunotherapy.

Garrido F, Aptsiauri N, Doorduijn EM, Garcia Lora AM, van Hall T. Garrido F, et al. Curr Opin Immunol. 2016 Apr;39:44-51. doi: 10.1016/j.coi.2015.12.007. Epub 2016 Jan 18. Curr Opin Immunol. 2016. PMID: 26796069 Free PMC article. Review.

9

Role of altered expression of HLA class I molecules in cancer progression.

Aptsiauri N, Cabrera T, Mendez R, Garcia-Lora A, Ruiz-Cabello F, Garrido F. Aptsiauri N, et al. Among authors: garrido f. Adv Exp Med Biol. 2007;601:123-31. doi: 10.1007/978-0-387-72005-0_13. Adv Exp Med Biol. 2007. PMID: 17712999 Review.

10

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.

Romero JM, Jiménez P, Cabrera T, Cózar JM, Pedrinaci S, Tallada M, Garrido F, Ruiz-Cabello F. Romero JM, et al. Among authors: garrido f. Int J Cancer. 2005 Feb 10;113(4):605-10. doi: 10.1002/ijc.20499. Int J Cancer. 2005. PMID: 15455355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results